• Hematologic Malignancy Center

    Dr. Lewis Silverman with Patient

    The Hematologic Malignancy Center at Dana-Farber/Boston Children's is one of the top centers of its kind in the world. We offer specialized programs for the treatment of leukemia, lymphoma, histiocytosis, and lymphadenopathy. Our center played a key role in refining treatment for childhood leukemia, resulting in today's cure rates of more than 90 percent for pediatric acute lymphoblastic leukemia, and we continue to lead high-impact clinical trials designed to increase cure rates and decrease treatment-related toxicities for long-term survivors.

    Highlights of the Hematologic Malignancy Center include:

    • Highly specialized hematologists/oncologists who are world leaders in their field
    • Quick and accurate diagnosis from our pediatric hematopathology service, one of the few dedicated pediatric programs in the U.S.
    • Advanced diagnostic techniques, including multiparameter flow cytometry and next generation sequencing genetic testing to detect key mutations that might be treated through targeted therapy (precision medicine)
    • Specialized methods to detect minimal residual disease (levels of disease that cannot be seen under a microscope)
    • Cutting-edge immunotherapies, including CAR T-cell therapy
    • Outpatient pediatric anesthesia program to minimize pain and discomfort associated with diagnostic and therapeutic procedures (including bone marrow aspirates/biopsies and lumbar punctures)
    • Innovative treatment options, including a large portfolio of innovative, early phase clinical trials for patients with relapsed and refractory cancer
    • Access to an internationally recognized pediatric Stem Cell Transplant Center
    • Innovative programs to improve quality of life during and after treatment, including the back-to-school program, home hydration program (to minimize time spent in the hospital receiving chemotherapy), and multiple, age-appropriate activities and outings with child-life specialists
    • fertility preservation small

      Fertility Preservation

      A specialized program for patients receiving cancer treatment who have experienced a decrease or loss of reproductive function.

    • survivor small

      Survivorship Services

      Providing care and advocacy for survivors of childhood cancer through ongoing education, support, and research on the long-term effects of cancer treatments.

    • psychosocial oncology

      Psychosocial Services

      Social workers, psychologists, and resource specialists offering help with the social, emotional, and psychological aspects of caring for children with cancer.

  • Ranked #1 for Cancer Care

    U.S. News Best Children's Hospitals logoU.S. News & World Report ranked Dana-Farber/Boston Children's the #1 pediatric cancer hospital in the nation.

  • Sarah Levin's Story

    Sarah Levine Leukemia Story

    Sarah Levin is 11 years old and has beaten acute lymphoblastic leukemia (ALL) twice. This is her story in her own words.

  • Our Affiliations

    HMS Callout FAD 

    Dana-Farber/Boston Children's is a teaching affiliate of Harvard Medical School.